Drug shortage
Oxaliplatin Injection · Jiangsu Hengrui Pharmaceuticals Co., Ltd.
FDA drug shortage · To Be Discontinued · updated Jun 29, 2026
Key facts
| Generic name | Oxaliplatin Injection |
|---|---|
| Company | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| Presentation | Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Oncology |
| Package NDCs | 25021-233-20 |
| First posted | Jun 29, 2026 |
| Last updated | Jun 29, 2026 |
| Discontinued | Jun 29, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: